middle.news

Avecho Addresses ASX Price Query Amid Speculation on CBD Trial Milestone

7:53am on Monday 2nd of June, 2025 AEST Biotechnology
Read Story

Avecho Addresses ASX Price Query Amid Speculation on CBD Trial Milestone

7:53am on Monday 2nd of June, 2025 AEST
Key Points
  • Avecho denies any undisclosed material information affecting recent share price
  • Trading activity possibly driven by speculation on Phase III CBD insomnia trial results
  • Company confirms compliance with ASX Listing Rule 3.1
  • Board-authorised response aims to reassure investors amid heightened trading volume
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Avecho Biotechnology (ASX:AVE)
OPEN ARTICLE